Please check your internet connection and try again.
# Ecospirin (Aspirin Enteric-Coated)
## Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) and antiplatelet agent. The enteric coating is designed to delay absorption until the drug reaches the small intestine, potentially reducing gastric irritation.
## Primary Indications
* Cardiovascular risk reduction (secondary prevention of myocardial infarction, stroke)
* Pain and inflammation (less common for this specific formulation due to delayed absorption)
## Adult Dosing
* **Cardiovascular risk reduction:** 75 mg to 100 mg once daily. Higher doses may be used in specific situations, but generally, lower doses are preferred for antiplatelet effects.
* **Dose adjustments:** No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised (see Contraindications and Monitoring).
## Pediatric Dosing
* Aspirin is generally **contraindicated** in children and adolescents for fever or viral illnesses due to the risk of Reye's syndrome.
* Specific pediatric indications and dosing for aspirin are limited and should be guided by expert recommendations and confirmed with current guidelines.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* Active peptic ulcer disease or history of recurrent ulcerations.
* Bleeding disorders (e.g., hemophilia, von Willebrand disease).
* Severe hepatic impairment.
* Severe renal impairment (CrCl < 30 mL/min).
* Asthma with nasal polyps and angioedema.
* Concomitant use with methotrexate at doses of 15 mg/week or higher.
* Children and adolescents with viral infections (risk of Reye's syndrome).
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, GI bleeding, ulceration.
* **Hematologic:** Increased bleeding time, bruising, epistaxis, hemorrhagic stroke.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema.
* **Other:** Tinnitus (especially at higher doses), dizziness, renal impairment.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 inhibitors:** Increased risk of GI bleeding and renal toxicity.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding.
* **Methotrexate:** Increased methotrexate toxicity.
* **Antihypertensives:** May decrease the efficacy of some antihypertensive agents.
* **Uricosuric agents:** May decrease the efficacy of agents used to treat gout.
## Monitoring
* **Signs of GI bleeding:** Melena, hematemesis, abdominal pain.
* **Signs of bleeding:** Easy bruising, prolonged bleeding from cuts, epistaxis.
* **Renal function:** Especially in patients with pre-existing renal disease or those taking other nephrotoxic agents.
* **Hepatic function:** If indicated.
* **Tinnitus:** May indicate therapeutic drug accumulation or toxicity.
## Clinical Pearls
* The enteric coating prevents dissolution in the stomach but can delay the onset of action for pain and fever relief compared to non-enteric coated aspirin. This formulation is generally preferred for chronic antiplatelet therapy.
* Patients should be advised to swallow the tablet whole and not to crush, chew, or break it.
* Even with enteric coating, GI side effects can still occur.
* Discontinue aspirin at least 5-7 days before elective surgery if clinically appropriate.
***
**Disclaimer:** This information is intended for clinical use and does not replace professional medical judgment. Always consult the most current prescribing information and relevant guidelines before making any treatment decisions.
